Clinical Research Directory
Browse clinical research sites, groups, and studies.
Neoadjuvant Immunotherapy of Operable Metastatic Melanoma in Real Life (GCC)
Sponsor: Centre Hospitalier Universitaire de Besancon
Summary
This study aims to evaluate efficacy and tolerance of real life neoadjuvant immunotherapy in advanced yet operable melanoma. The complete histological response will be assessed.
Official title: ETUDE NEOMEL: TRAITEMENT NEOADJUVANT PAR IMMUNOTHERAPIE DU MELANOME METASTATIQUE OPERABLE EN VIE REELLE (GCC)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
77
Start Date
2023-03-24
Completion Date
2025-01
Last Updated
2024-09-19
Healthy Volunteers
No
Conditions
Locations (9)
CHU Angers
Angers, France
CHU de Besançon
Besançon, France
Hôpital Avicenne
Bobigny, France
CH de Boulogne-sur-Mer
Boulogne-sur-Mer, France
CHU Clermont-Ferrand
Clermont-Ferrand, France
Centre de Lutte Contre le Cancer Léon Bérard
Lyon, France
ICO René Gauducheau
Saint-Herblain, France
Institut Universitaire de Cancérologie de Toulouse
Toulouse, France
CH de Valence
Valence, France